Home › NDC Lookup › RxCUI directory › RxCUI 1551993

Cobicistat 150 MG Oral Tablet — RxCUI 1551993

RxNorm drug concept · Semantic clinical drug
RxCUI 1551993 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1551993
Official nameCobicistat 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)42 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cobicistat: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tybost isn't an HIV treatment on its own. Think of it as a helper drug — it slows down your body's process of breaking down your actual HIV medicine (atazanavir or darunavir), so t...
  • What exactly does Tybost do — is it treating my HIV?
  • Yes, every time. Tybost should always be taken with food, at the same time as your atazanavir or darunavir. Taking it with food is part of how the regimen is designed to work. Try...
  • Do I have to take Tybost with food every time?
📖 Read our full Cobicistat guide →

🕸️ Concept Web — How Cobicistat 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cobicistat 150 MG Oral Tablet RxCUI 1551993

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cobicistat 1306284
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tybost 1551994
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cobicistat Oral Tablet 1551992
    • Cobicistat Oral Product 1551990
    • Cobicistat Pill 1551991
    • Cobicistat Oral Tablet [Tybost] 1551996
    • Tybost Oral Product 1551997
    • Tybost Pill 1551998
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cobicistat 150 MG SCDC · 1306285
  • Cobicistat Oral Tablet SCDF · 1551992
  • Cobicistat Oral Product SCDG · 1551990
  • Cobicistat Pill SCDG · 1551991

Brand-Name Concepts

  • Cobicistat 150 MG Oral Tablet [Tybost] SBD · 1551999
  • Cobicistat 150 MG [Tybost] SBDC · 1551995
  • Cobicistat Oral Tablet [Tybost] SBDF · 1551996
  • Tybost Oral Product SBDG · 1551997
  • Tybost Pill SBDG · 1551998
  • Tybost BN · 1551994

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1551993 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61958-1401-01 30 TABLET, FILM COATED in 1 BOTTLE (61958-1401-1) Tybost Gilead Sciences, Inc. 2014-09-24
Observed labelers: Gilead Sciences, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.